BioSpace News Archive

Halberd Corporation (OTC PINK:HALB) has demonstrated the ability to selectively reduce and control the level of one element in a heterogeneous mixture containing two elements without affecting the levels of the second element.

Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes, announced the publication of two-year durability data from its REVITA-1 clinical study conducted at centers in Europe and South America.

Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA ® Blood Test.

Acer Therapeutics Inc. announced that Acer’s management team will virtually participate in the BIO CEO & Investor Conference on February 14-17, 2022.

Veru Inc. today announced that it has entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company.

Quotient Limited, a commercial-stage diagnostics company headquartered in Eysins, Switzerland, announced its attendance for the first time to the Arab Health and Medlab Middle East Conference in Dubai, United Arab Emirates.

Rubius Therapeutics, Inc. announced that the executive management team will present and host meetings with investors at the virtual Guggenheim Healthcare Talks and SVB Leerink Global Healthcare Conference in February.

Further to its press release dated September 15, 2021, IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) today announced that its wholly-owned subsidiary, IntelGenx Corp. (“IntelGenx”) has received a third term loan (the “Third Loan”) in the amount of U.S.$3 million pursuant to its amended and restated secured loan agreement with atai Life Sciences (“atai”).

Aldeyra Therapeutics, Inc. today announced that results from the randomized, double-masked, vehicle-controlled, crossover Phase 2 clinical trial of reproxalap in an allergen chamber model have been published in the peer-reviewed journal Clinical Ophthalmology.

Biosero, Inc. today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform.